Decreased expression of angiogenesis antagonist EFEMP1 in sporadic breast cancer is caused by aberrant promoter methylation and points to an impact of EFEMP1 as molecular biomarker
2009 ◽
Vol 124
(7)
◽
pp. 1727-1735
◽